Dietary (n-3) fatty acids alter plasma fatty acids and leukotriene B synthesis by stimulated neutrophils from healthy geriatric Beagles by NC DOCKS at The University of North Carolina at Greensboro & Wander, Rosemary
Dietary (n-3) fatty acids alter plasma fatty acids and leukotriene B synthesis by stimulated 
neutrophils from healthy geriatric Beagles
 
By: J.A. Hall
*
, L.R. Henry, S. Jha
†
, M.M. Skinner
‡
, D.E. Jewell
§
, and R.C. Wander
**
 
 
Hall, J.A., Henry, L.R.,  Jha, S., Skinner, M.M., Jewell, D.E., and Wander, R.C. 2005. Dietary 
(n-3) fatty acids alter plasma fatty acids and leukotriene B synthesis by stimulated 
neutrophils from healthy geriatric Beagles. Prostaglandins, Leukotrienes, Essential Fatty 
Acids. Nov 73(5): 335-341.  
 
Made available courtesy of Elsevier: 
http://www.elsevier.com/wps/find/journaldescription.cws_home/623065/description#description 
 
***Note: Figures may be missing from this format of the document 
 
Abstract: 
The study objective was to determine the effect of feeding food enriched in (n-3) fatty 
acids (FA) on plasma FA profiles and leukotriene B (LTB) synthesis by stimulated 
peripheral blood neutrophils from dogs. For 36 weeks, two groups of dogs (n = 5) were fed 
food that contained either a low ratio of (n-6)–(n-3) FA (1.31:1; fish oil-enriched food) or a 
high ratio of (n-6)–(n-3) FA (40.6:1; corn oil-enriched food). Consumption of food 
enriched in fish oil resulted in higher plasma concentrations of eicosapentaenoic acid and 
docosahexaenoic acid and lower concentrations of arachidonic acid. Neutrophils from 
dogs fed fish oil-enriched food produced 7.6-fold more LTB5 (P = 0.002), and the ratio of 
LTB5–LTB4 concentrations was 8.3-fold higher (P<0.001) compared with dogs fed corn oil-
enriched food. Dietary FA can modulate leukotriene production by neutrophils in dogs, 
and suggests that foods enriched in (n-3) FA from fish oil may have value in the 
treatment of canine inflammatory diseases. 
 
Article: 
1. Introduction 
A variety of diets and fatty acid (FA) supplements rich in (n-3) fatty acids (FAs) from fish 
oil are currently marketed for use in dogs. We have previously shown that healthy, geriatric 
Beagles fed foods enriched in (n-3) FAs from fish oil for 12 weeks have altered plasma FA 
profiles [1], similar to what has been reported in humans, horses, and laboratory animals [2–5]. 
In addition, a ratio of dietary (n-6)–(n-3) FAs of 1.4:1 depressed cell- mediated immunity, 
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based on results of a delayed-type hypersensitivity (DTH) skin test, and decreased pros-
taglandin E2 (PGE2) production by stimulated mononuclear cells [1]. Altering the ratio 
of (n-6)–(n-3) FAs also affected T-cell subpopulations in aged dogs, in that after 
immunization with a novel protein these dogs had decreased numbers of CD4+ 
lymphocytes and decreased CD4
+
-to-CD8
+
 ratios [6]. Furthermore, we have shown 
that there is an interaction between dietary vitamin E and (n-3) FAs such that the effects 
of an optimum amount of dietary vitamin E concentration on the DTH response are 
blunted by dietary (n-3) FAs [7]. This study is a continuation of these investigations in 
aged Beagles, whereby we report the effect of consumption of a diet enriched in (n-3) FAs 
for 36 weeks on plasma FA profiles and on leukotriene (LT) B4 and LTB5 production 
by peripheral blood neutrophils. 
 
The type of LT that cells produce, and consequently, communication between cells of the 
immune system, can potentially be modulated through dietary supplementation of (n-3) 
FAs [2,8–10]. When immune cells are activated by a chemical or physical insult, FAs 
are mobilized from cell membrane phospholipids and  metabolized into eicosanoids 
[11]. Leukotrienes are eicosanoids with chemotactic properties; they are  also involved 
in regulation of inflammatory and immune processes. Arachidonic acid [AA; 20:4(n-6)] 
is a 20 carbon (n-6) polyunsaturated FA that is incorporated into cell membrane 
phospholipids. In neutrophil  cell membranes, AA is metabolized by 5-lipoxygenase to 
yield LTA4, which is converted to LTB4 by LTA4-hydrolase. Production of LTB4 
by stimulated peripheral blood neutrophils reflects the plasma concentration of AA, the 
FA from which LTB4 is derived [3]. Leukotrienes of the 4-series regulate inflammatory 
cytokine production [8]. The types of leukotrienes produced from eicosapentaenoic 
acid [EPA; 20:5 (n-3)], a 20 carbon (n-3) polyunsaturated FA, are less biologically 
potent than analogues synthesized from AA [8]. For example, LTB5 which is 
produced by metabolism of EPA, is 10-fold less potent as a  neutrophil 
chemoattractant than LTB4 [12,13]. 
 
The goal of this investigation was to determine the effect of feeding different amounts of (n-3) 
FAs on plasma FA profiles and leukotriene production by peripheral blood neutrophils from 
dogs. To achieve this goal, we measured LTB4 and LTB5 production by calcium-ionophore 
stimulated peripheral blood neutrophils of dogs fed either corn oil- or fish oil- enriched foods. 
 
2. Materials and methods  
 
2.1. Animals 
Ten healthy, female, geriatric (7- to 10-year-old) Beagles that weighed between 7.6 and 13.1 kg 
were selected for this study (Hill’s Pet Nutrition Inc., Topeka, KS, USA). 
 
All dogs had been previously vaccinated against canine distemper, parvovirus, and 
rabies according to standard protocols, and none had chronic systemic  disease, as 
determined on the basis of results of physical examination, complete blood count (CBC) 
determination, serum biochemical analyses, urinalysis, and fecal examination for parasites. 
Dogs were housed in pairs of two in indoor runs and fed once daily in the morning. Dogs 
experienced enrichment through interactions with each other and with the caretakers. Four 
additional healthy Beagles used in the teaching program at the College of Veterinary 
Medicine, Oregon State University, Corvallis, OR, USA were also included in the study. 
The experimental protocol was reviewed and approved by the Oregon State University 
Animal Care and Use Committee in accordance with principles  outlined by the 
National Institutes of Health [14].  
 
2.2. Foods 
For 90 days before the study, the experimental dogs consumed a commercial food (Science 
Diet Canine Maintenance, Hill’s Pet Nutrition Inc.) without enhancement of (n-6) and 
(n-3) FAs. The ratio of (n-6)– (n-3) FAs was 18:1 (Table 1). The source of (n-3) FAs in this 
food was 90% plant-derived from a-linolenic acid (soybean oil). The healthy Beagles used in 
the teaching program also consumed the same baseline food (Science Diet Canine 
Maintenance, Hill’s Pet Nutrition Inc.) as the experimental dogs, before the latter were 
switched to their respective experimental foods. 
 
The experimental foods were prepared by a commercial company (Hill’s Pet Nutrition Inc.). 
Experimental foods varied in the amount of (n-3) FAs they contained. The low (n-3) FA 
food contained a minimal amount of (n-3) FAs (0.5g [n-3] FAs/kg of food, wet-weight 
basis) and, thus, had a high ratio of (n-6)–(n-3) FAs (40.6:1). The high (n-3) FA food 
contained a larger amount of (n3) FAs from fish oil (5.9 g [n-3] FAs/kg of food, wet- weight 
basis) and had a low ratio of (n-6)–(n-3) FAs (1.31:1). The amount of 18:3(n-3) FA (a-
linolenic acid) was low in both foods and roughly equivalent. Both foods contained 101 
mg/kg of all-rac-a-tocopherol acetate. The basal food ingredients (by weight) included 
54.8% water, 20.3% turkey, 15.0% corn, 4.5% pork liver, 2.0% soy meal, 1.0% beet pulp 
and 0.4% vitamin and mineral premixes. Rice hulls were used as the carrier for the vitamin 
premix, which contained 25 mg/kg cholecalciferol, 7500 mg/kg nictotinic acid, 5000 mg/kg 
calcium D-pantothenate, 21,800mg/kg thiamine mono- nitrate, 1250 mg/kg riboflavin, 2430 
mg/kg pyridoxine hydrochloride, 250 mg/kg folic acid, 50 mg/kg biotin and 50mg/kg vitamin 
B-12. Calcium carbonate was used as the carrier for the mineral mix, which contained 80 
g/kg zinc as zinc oxide, 6.0 g/kg manganese as manganese oxide, 280 g/kg iodine as 
calcium iodate, 1.0 g/kg cobalt as cobalt carbonate, 180 mg/kg selenium as selenium 
selenite, and 2.5 g/kg copper as copper chloride. The remaining 2% of the food was provided 
as added oil. The source of oil for the (n-3) enriched food was Menhaden fish oil (Menhaden 
fish oil, Zapata Protein, Reedville, VA, USA), whereas the source for the (n-6) enriched food 
was corn oil (Mazola corn oil, Mazola, Englewood Cliffs, NJ, USA). Foods were analyzed 
at a commercial laboratory (Woodson-Tenent Laboratories, Des Moines, IA, USA). 
Nutrient composition (by weight) was 77.4% moisture, 5.8% protein, 4.5% fat, 1.3% ash and 
0.7% crude fiber and 10.3% carbohydrate. FA composition of the two experimental foods 
was determined (Table 1). 
 
2.3. Study design 
Dogs were ranked on the basis of body weight and assigned to two groups of five dogs 
each, such that body 
Table 1 
Composition of selected fatty acids in foods fed to geriatric Beagles     
Fatty acid Baseline food without Corn oil-enriched food with 
enhancement of (n-6) and (n-3) low (n-3) fatty acid content 
fatty acid content (g/kg of food) (g/kg of food) 
Fish oil-enriched food with 
high (n-3) fatty acid content 
(g/kg of food) 
14:0 0.2 0.2     1.4     
16:0 6.9 7.5     7.1     
18:0 3.3 2.5     2.3     
Sum of SFAt 10.4 10.2     10.9     
16:1(n-7) 0.9 1.1     2.5     
18:1(n-9)c 12.4 14.5     9.0     
Sum of MUFA$ 13.6 15.8     11.8     
18:2(n-6) 7.2 19.9     7.2     
18:3(n-3) 0.3 0.5     0.5     
18:4(n-3) <0.1 <0.1     0.6     
20:4(n-6) 0.1 0.4     0.5     
20:4(n-3) <0.1 <0.1     0.3     
20:5(n-3) <0.1 <0.1     1.9     
22:5(n-3) <0.1 <0.1     0.4     
22:6(n-3) <0.1 <0.1     2.2     
Sum of PUFA§ 8.0 20.8     13.3     
Sum of (n-6) fatty acids 7.5 20.3     7.7     
Sum of (n-3) fatty acids 0.4 0.5     5.9     
Ratio (n-6)–(n-3) 18.0:1 40.6:1     1.31:1     
tSum of the saturated fatty acids (SFA) was determined as follows: 8:0+ 10:0+ 11:0+ 12:0+ 14:0+ 15:0+ 16:0+ 17:0+ 18:0 +20:0 +22:0 +24:0. 
$Sum of the monounsaturated fatty acids (MUFA) was determined as follows: 14:1 + 15:1 + 16:1(n -7) + 17:1 + 18:1(n-9)c+ 
18:1(n-7)+ 18:1 (n-9)t+ 20:1(n-9) + 22:1(n-9) + 24:1. 
§Sum of the polyunsaturated fatty acids (PUFA) was determined as follows: 18:2(n -6)+18:3(n-6)+18:3(n-3)+18:4(n-
3)+20:2(n-6)+20:3 (n-6) + 20:3(n-3) + 20:4(n-6) + 20:4(n-3) + 20:5(n-3) + 21:5(n-3) + 22:2(n-6) + 22:4(n-6) + 22:5(n-6) + 22:5(n-3) + 
22:6(n-3). 
weights were evenly distributed between the groups. Body weights were measured before 
the study began and weekly during the study. Food intake was quantitated and adjusted 
such that dogs did not gain or lose weight. Blood samples were collected after the 
experimental dogs had consumed their respective foods for 36 weeks. Blood samples were 
collected from the healthy Beagles used in the teaching program after they had consumed 
the baseline food for 4 weeks. Blood samples were collected before the daily meal 
offering into evacuated tubes containing EDTA (final concentration, 1.5 g/L), and plasma 
was harvested. 
 
2.4. Plasma FAs 
FA content of plasma samples was determined by use of gas chromatography, as previously 
described [15], using heptadecanoic acid as the internal standard. FA concentration was 
expressed as g/100g of FAs. 
 
2.5. Leukotriene B4 and B5 quantification 
Neutrophils were isolated and purified as previously described [16] from blood collected at 
36 weeks for the experimental dogs and at 4 weeks for the healthy Beagles used in the 
teaching program. Aliquots of 1 x 10
6
 neutrophils were transferred to test tubes and the 
volume adjusted to 495 µL with Hanks balanced salt solution containing 0.8 mmol/L 
CaCl2. Neutrophils were then stimulated with 5µL of calcium ionophore A23187 (Sigma 
Chemical Co., St. Louis, MO, USA) in 0.2% dimethyl sulfoxide (Syntex, West Des Moines, 
IA, USA) such that the final concentration of A23187 was 10 mmol/L, while 
unstimulated neutrophils received 5 µL of 0.2% dimethyl sulfoxide without calcium 
ionophore. All tubes were incubated for 5 min at 37'C as previously described [16]. 
Supernatants were stored at -70'C until subsequent LTB4 and LTB5 measurements were 
made. LTB4 and LTB5 were extracted, separated, and quantified as previously described 
[16]. Standard calibration curves for LTB4 and LTB5 were made by adding 100 ng of 
PGB3 as an internal standard to samples containing 0.47–40 ng of LTB4 and LTB5 
(Sigma). PGB3 was chosen as the internal standard because it was widely separated from 
LTB4 present in actual samples during HPLC separation, whereas PGB2 coeluted with LTB5 
and PGB1 coeluted with LTB4 [17]. Concentrations of leukotrienes in test samples were 
calculated with reference to the standard curves. Final LTB4 and LTB5 concentrations 
were reported as nanograms of LTB4 and LTB5 per 1 x 10
6
 cells. 
 
2.6. Statistical analysis 
Data are reported as means ±SEM. Using the Kolmogorov–Smirnov test, data that 
were found to be normally distributed were analyzed using analysis of variance. On the 
basis of the Homogeneity of Variance test, data that were homoscedastic were analyzed 
using analysis of variance followed by post hoc separation of the means using the Tukey–
Kramer Multiple-Comparison test. When the assumptions of normality and equal variance 
were suspect, data were analyzed by the  nonparametric Kruskal–Wallis Test, followed 
by post hoc separation of the means using the Kruskal–Wallis Z-Test. Correlations were 
evaluated with the Pearson correlation test. Overall significance was set at P<0.05. 
Statistical analyses were performed using the Number Cruncher Statistical System (NCSS) 
(Kaysville, UT, USA), version 2004 (www.ncss.com). 
 
3. Results 
 
3.1. Animals and foods 
All dogs readily consumed their respective FA- enriched foods. At the beginning of 
the study dogs consuming the high (n-3) FA food weighed 10.0±0.7 kg (mean±SEM). At 
the end of the study these dogs weighed 10.8±0.7kg. At the beginning of the study the 
dogs consuming the low (n-3) FA food weighed 10.5 ± 0.8 kg (mean ± SEM). At the 
end of the study these dogs weighed 12.5±0.9 kg. Body weights were not significantly 
different between groups, although dogs consuming the low (n-3) FA food weighed 
significantly more after 36 weeks compared to baseline (P = 0.02). 
 
3.2. Plasma FA profiles 
The FA composition of plasma at the beginning of the study was similar for experimental dogs 
regardless of the projected dietary intervention (Table 2). The healthy Beagles used in the 
teaching program differed from the experimental dogs in total saturated fatty acids 
(SFA)(P<0.001), arachidonic acid (P<0.001), total polyunsaturated fatty acids (PUFAs) (P = 
0.01), and total (n-6) FAs (P = 0.01). Plasma from these dogs had approximately 18% more 
SFA (primarily palmitic acid and to a lesser extent myristic acid) than experimental dogs, 
and 18% less AA. This resulted in total PUFAs and total (n-6) FAs being approximately 
8% less in these dogs compared to experimental dogs at baseline. 
 
As expected, after feeding the two experimental foods for 36 weeks, plasma FA 
compositions changed substantially (Table 2). Sum of the (n-6) FAs, sum of the (n-3) 
FAs, and ratio of (n-6)–(n-3) FAs reflected the dietary composition of the respective FAs in 
the foods fed. Although plasma total (n-3) FAs (P<0.001), including EPA (P<0.001) and 
DHA (P<0.001), were significantly higher in dogs fed fish-oil enriched food compared to 
dogs fed corn oil-enriched food, total (n-6) FAs (P < 0.00 1), including linoleic acid (LA) (P < 
0.001) and AA (P<0.001), were significantly lower such that 
Table 2 
Mean (±SEM) plasma concentration of fatty acids in geriatric Beagles before and after dietary intervention for 36 weeks with food 
that differed in the ratio of (n-6)–(n-3) fatty acids 
Fatty Acid 
Baseline food 
4 weeks 
Corn oil-enriched food with low (n-3) fatty 
acid content 
Fish oil-enriched food with high (n-3) fatty 
acid content 
Baseline 36 weeks Baseline 36 weeks 
14:0 0.9±0.1ax 0.1±0.1b 0.3±0.1y 0.5±0.1a 0.9±0.2x 
16:0 16.6±0.5ax 9.4±0.4b 12.9±0.5y 11.0±0.5b 14.7±1.0 
18:0 20.4±0.4 20.6±0.8 20.4±0.6 18.7±0.6 19.6±0.9 
Sum of SFAt 38.6±1.0ax 32.5±0.3b 33.7±0.6y 32.9±0.2b 35.7±1.1 
18:1(n-9)c 9.3±0.5x 10.6±0.5 8.0±0.1y 10.7±0.4 7.9±0.2y 
Sum of MUFA$ 14.1±0.6x 15.8±0.5 11.3±0.4y 15.8±0.5 15.1±0.6x 
18:2(n-6) 23.8±0.8x 22.9±0.6 32.9±1.2y 22.8±0.7 21.2±1.3x 
20:4(n-6) 19.4±0.7ax 24.3±0.7b 19.4±0.9x 23.3±0.3b 11.8±0.4y 
20:5(n-3) 0.2±0.1x 0.2±0.1 0.1±0.0x 0.1±0.1 6.6±0.5y 
22:6(n-3) 0.6±0.1x 0.7±0.1 0.4±0.2x 0.6±0.1 4.3±0.6y 
Sum ofPUFA § 46.9±1.4ax 51.2±0.7b 54.9±0.9y 50.3±0.4b 49.1±1.0x 
Sum of (n-6) fatty acids 44.0±1.5ax 48.4±0.6b 53.0±1.3y 47.7±0.4b 34.5±1.2z 
Sum of (n-3) fatty acids 2.7±0.2x 2.9±0.2 1.4±0.2x 2.6±0.2 12.9± 1.4y 
Ratio (n-6)–(n-3) 16.4±1.5x 17.1±0.9 40.5±5.5y 18.9±1.7 2.9±0.5z 
 
A separate group of healthy Beagles used in the College teaching program were fed baseline food for 4 weeks. 
abMean values with different letters are significantly different (P<0.05) at baseline, before dietary 
intervention. xyzMean values with different letters are significantly different (P<0.05) after dietary 
intervention. 
t$§See Table 1 for remainder of key. 
 
total PUFAs (P = 0.003) were significantly lower after consumption of high (n-3) food. Plasma 
concentration of total monounsaturated fatty acids (MUFAs)  (P = 0.002) was 
significantly higher in dogs fed fish oil-enriched food, whereas plasma concentrations of 
SFAs did not differ significantly between the dogs fed the high and low (n-3) FA foods. 
 
The baseline food was not enhanced in (n-6) and (n-3) FAs compared to the experimental 
foods, and, thus after the experimental foods were fed for 36 weeks, the plasma ratio of 
(n-6)–(n-3) FAs in the healthy Beagles used in the teaching program (16.4:1) was 
intermediate between the plasma ratios of (n-6)–(n-3) FAs for the corn oil-fed dogs 
(40.5:1) and fish oil-fed dogs (2.9:1), and all were significantly different from each 
other (P<0.001). Plasma total (n-3) FAs (P<0.001), EPA (P<0.001), and DHA (P<0.001) 
were significantly higher in the dogs fed the fish oil-enriched food compared to dogs 
fed baseline food, but were similar in dogs fed the baseline food and the corn oil-
enriched food. Plasma total (n-6) FAs (P<0.001) and AA (P<0.001) in dogs fed the fish 
oil-enriched food were lower than those in dogs fed baseline food, but because EPA and 
DHA were increased in dogs fed the fish oil-enriched food, the total PUFA levels (P = 
0.003) were similar between the dogs fed baseline food and those fed fish oil-enriched food. 
Total PUFAs (P = 0.003) were significantly higher in dogs fed corn oil-enriched food 
compared to dogs fed the baseline food, primarily because LA (P<0.001) (but not 
AA), and thus, total (n-6) FAs (P<0.001), were significantly higher in dogs fed corn oil-
enriched food. Total SFAs (P = 0.02) and total MUFAs (P = 0.002) (including oleic acid [P 
= 0.02]) were also lower in dogs fed the corn oil-enriched food compared to plasma 
levels in dogs fed baseline food. Total SFAs (P = 0.02) and oleic acid (P = 0.02) (but not 
total MUFAs) were lower in dogs fed the fish oil-enriched food compared to plasma levels 
in dogs fed baseline food. 
 
3.3. LTB4 and LTB5 quantification 
Neutrophils from dogs fed fish oil-enriched food produced 7.6-fold more LTB5 (P = 
0.002) compared with dogs fed corn oil-enriched food (Fig. 1). No LTB5 was detected in 
supernatants of stimulated neutrophils from dogs fed baseline food. Similar amounts of 
LTB4 were produced by stimulated neutrophils from dogs in all three groups. The ratio 
of LTB5 to LTB4 concentrations was 8.3-fold higher (P<0.001) in dogs fed fish oil-enriched 
food compared with dogs fed corn oil-enriched food (0.50 vs. 0.06, respectively). The 
ratio of EPA to AA in the plasma across dietary treatments wascorrelated 
(correlation coefficient= 0.83, P<0.001) tothe ratio of LTB5–LTB4 concentrations. 
Fig. 1. Effect of feeding geriatric Beagles foods for 36 weeks that differed in the (n-6) 
and (n-3) fatty acid content on the production of LTB5 and LTB4 by stimulated 
peripheral blood neutrophils. A separate group of healthy Beagles used in the College 
teaching program were fed baseline food for 4 weeks. Data are expressed as nanograms per 
1 x 10
6
 cells (mean±SEM). Bars with P-values abovethem indicate when mean values 
differed significantly (P<0.05). Different lower case letters above bars indicate which 
groups are significantly different (P<0.05). 
 
4. Discussion 
The principal findings in this study were that production of LTB5 and LTB4 from canine 
peripheral blood neutrophils reflected the plasma concentration of substrates EPA and AA, 
respectively, from which they are derived. In turn, the plasma content of EPA and AA are 
dependent on the dietary concentrations of these FAs. Consumption of food enriched in fish oil 
resulted in higher plasma concentrations of EPA and DHA, and lower plasma concentrations of 
AA than consumption of food enriched in corn oil. Consequently, stimulated neutrophils from 
dogs consuming fish oil-enriched food produced higher levels of LTB5. Consumption of food 
enriched in corn oil resulted in higher plasma concentrations of LA, but not AA. There was no 
significant difference in the production of LTB4 by stimulated neutrophils from dogs consuming 
food enriched in corn oil compared to dogs consuming food enriched in fish oil. 
 
These results are similar in part to what has been previously reported for canine 
neutrophils. Experimental foods containing (n-6)–(n-3) ratios of 5:1, 10:1, 25:1, 50:1, and 
100:1 were fed to Beagle dogs for 12 weeks [18]. Neutrophils from dogs fed 5:1 and 
10:1 foods synthesized 370–500% greater LTB5 and 30–33% less LTB4 after 6 and 12 
weeks of treatment feeding compared to 0 weeks. Our dogs fed fish oil-enriched 
foods produced 760% more LTB5 compared with dogs fed corn oil-enriched foods. The 
decrease in LTB4 production by neutrophils from dogs fed foods with low (n-6)–(n-3) FA 
ratios in their study is consistent with the decrease in plasma AA concentration that we 
found in our dogs fed fish oil-enriched food, but we report no statistically significant 
change in LTB4 production after 36 weeks. It is possible that a small sample size and large 
variation between dogs for LTB4 production prevented us from detecting a decrease in 
LTB4 production in dogs fed fish oil-enriched food. Alternatively, even though AA 
content of plasma was significantly lower in dogs fed fish oil-enriched food compared to 
dogs fed corn oil- enriched food, perhaps it was not decreased enough to see a 
concomitant decrease in LTB4 synthesis by stimulated neutrophils. In humans, 
supplementation of the Western diet with icosapentaenoic acid for 4 weeks only slightly 
reduced AA content in human polymorphonuclear leukocytes, and consequently, there 
was unreduced synthesis of LTB4 by ionophore A23187 stimulated cells [19]. Our dogs 
fed fish oil-enriched food still received the same amount of (n-6) FAs/kg food as dogs fed 
baseline food. Our results in dogs also differ from our findings in horses [3], whereby 
feeding fish oil- supplements to horses results in an increase in plasma AA concentration 
and an increase in LTB4 production by stimulated neutrophils. 
 
Similar to what we reported for horses [3], our dogs consuming a fish oil-enriched food 
showed a strong correlation (correlation coefficient = 0.83) between the ra t i o  o f  EPA–
AA in  p l asma and the  ra t i o  o f  LTB5–LTB4 synthesized by stimulated 
neutrophils. The ratio  of plasma EPA–AA and the ratio of  LTB5–LTB4 production 
were higher in dogs receiving the fish oil-enriched food compared with dogs receiving the 
corn oil-enriched food. If the ratio of LTB5–LTB4 is important in the dog, as it is in other 
species, then a diet high in (n-3) PUFA is preferable to a diet high in (n-6) PUFA in terms of 
decreasing proinflammatory leukotrienes synthesis. Others have shown a linear relation-
ship between the ratio of EPA–AA in cell membrane phospholipids and the ratio of LTB5–
LTB4 produced by rat peritoneal exudate cells in vitro [5]. In that study, the content of EPA 
in cell membrane phospholipids was positively correlated with LTB5 synthesis and 
negatively correlated with LTB4 synthesis. The content of AA in cell membrane 
phospholipids was positively correlated with LTB4 synthesis. Altogether, these results 
suggest that EPA and AA are equally active substrates for 5- lipoxygenase. 
 
There is evidence that substrate concentration can enhance or inhibit production of 
eicosanoids [20–22]. EPA can act  as a  competit ive inhibitor  of AA  conversion to 
LTB4 [23]. Using rat alveolar macrophages, Kobayashi et al. [21] found that EPA 
inhibited endogenous production of LTB4 from AA. In addition, LTB4 production decreased 
in a dose-dependent fashion when cells were incubated with EPA [22]. At low 
concentrations of EPA, generation of LTB5 was increased, whereas at high 
concentrations of EPA, generation of LTB5 was decreased. These authors suggested 
that at low concentrations EPA may compete with AA as a substrate, and that at high 
concentrations it may directly inhibit AA metabolism by inhibiting 5- lipoxygenase or 
phospholipase A2. 
 
Results of our study suggest that a diet rich in (n-3) PUFA caused increased production of 
LTB5, which is less biologically active than LTB4, and may have inhibitory effects on 
the function of LTB4 [2]. Some studies suggest that the ratio of LTB5–LTB4 is more 
important than the absolute amounts of either eicosanoid [5,23–25]. For example, LTB5 
inhibited the ability of LTB4 (which was present in optimal concentrations for activity) to 
stimulate DNA synthesis in cultured human epidermal keratinocytes, and inhibited 
chemotaxis of human blood neutrophils in a dose-dependent manner [24]. The authors 
suggested that the inhibitory effect of LTB5 on LTB4 activity was related to 
competition for receptors. 
 
Dietary treatment for 36 weeks resulted in altered plasma FA profiles, which were 
consistent with the respective supplement’s FA profiles. Dogs consuming a fish oil-enriched 
food experienced an elevation of (n-3) FAs, predominantly EPA and DHA, and a decrease 
in (n-6) FAs, predominantly AA. Dogs were fed three times longer than in previous 
studies, demonstrating that changes in plasma FA profiles induced by short- term feeding 
(8–12 weeks) persist for longer periods of time as long as the dietary treatment is 
maintained. 
 
This study supports the hypothesis that feeding fish oil results in partial replacement 
of AA in cell membranes by EPA, which in turn leads to decreased production of AA-
derived eicosanoids. This may result from decreased availability of AA, competition of AA 
and EPA for lipoxygenase enzymes, and/or decreased expression of 5-lipoxgenase, as LTB4 
is a product of the 5-lipoxygenase pathway of AA metabolism. This would explain in part the 
anti-inflammatory effects of (n-3) FAs [10]. Alterations in leukotriene expression may also 
lead to altered gene expression through effects on transcription factor activation, such as 
nuclear factor- kappa B (NF-KB) [2,8,26]. It is known that dietary fish oil results in 
suppressed production of proinflammatory cytokines [8]. Recently, LTB4 was shown to 
increase monocyte chemoattractant protein-1 expression, a proinflammatory cytokine, and 
this increase was mediated via NF-KB [9]. LA has been shown to increase secretion of IL-8 
by Crohn’s human intestinal smooth muscle cells by stimulating production of AA metabo-
lites (LTB4, PGE2, and thromboxane B2 [TXB2]) [27]. Inhibition of 5-lipoxygenase 
(and thus production of LTB4) blocks IL-8 production. It is proposed that LTB4 
increases IL-8 production by enhancing NF-KB-dependent transcription of IL-8 [27]. 
Thus, neutrophils secreting LTB4 may promote production of a transcription factor, 
NF-KB, which leads to expression of proinflammatory cytokines. 
 
In summary, we have shown that enrichment of foods with fish oil increased production of 
the less inflammatory eicosanoid LTB5 in dogs. The ratio of plasma EPA–AA 
corresponded with the ratio of LTB5–LTB4 produced by stimulated canine neutrophils. 
Further studies are needed to determine the optimum ratio of LTB5–LTB4 
concentrations in canine inflammatory disorders, e.g., inflammatory bowel disease and 
pruritic dermatological conditions such as atopic dermatitis, for decreasing activation of NF-
KB and subsequent production of proinflammatory cytokines. 
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